Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Adipokines affect skin health and could be targeted for treating skin diseases.

The secretome from mesenchymal stem cells shows promise for treating skin conditions and improving skin and hair health, but more research is needed.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Sox6 is important in heart and kidney health, affecting diseases like diabetes, heart disease, and high blood pressure.